PharmaTimes

Indian essential drug prices to fall "up to 80%"

India's new Drug Price Control Order (DPCO) has now been introduced, and is expected to lead to reductions in the prices of 348 essential drugs by up to 80%.

...more World News

Shire's shenanigans continue; guilty of 10 Code breaches

This time the firm has been hit for ‘disparaging comparisons’ between its Gaucher's disease drug Vpriv and Genzyme’s rival treatment in a press release

...more UK News

Health Research Authority sets out stall on trial transparency

Making trial registration a condition of Research Ethics Committee approval and working with research funders and sponsors to set standards for access to data and human tissue are among proposals by the UK’s Health Research Authority (HRA) to ensure the publication of clinical and other health-research findings.

...more Clinical News

World News

Indian essential drug prices to fall "up to 80%"

India's new Drug Price Control Order (DPCO) has now been introduced, and is expected to lead to reductions in the prices of 348 essential drugs by up to 80%.
UCB and IBM bet on big data to help epilepsy

UCB has teamed up with IBM to "harness super-computer power" and help improve treatment for epilepsy patients
Sanofi to submit JAK inhibitor for MF

Sanofi is getting ready to file its JAK2 inhibitor for myelofibrosis on strong late-stage data for the rare, but serious blood disease
Bayer buys herbal drugmaker Steigerwald

Bayer has boosted its consumer care business by acquiring fellow Germany-based company Steigerwald Arzneimittelwerk, which specialises in pharmacy-only herbal medicines
A*Star and Cytos advance Singapore's first flu vaccine

Singapore’s Agency for Science, Technology and Research (A*Star) and Switzerland’s Cytos Biotechnology say that the first healthy volunteer has been dosed in a Phase I trial with their H1N1 influenza vaccine candidate

UK News

Shire's shenanigans continue; guilty of 10 Code breaches

This time the firm has been hit for ‘disparaging comparisons’ between its Gaucher's disease drug Vpriv and Genzyme’s rival treatment in a press release
NICE thumbs up for new Astellas bladder drug

Betmiga gets final draft yes from the Institute as Astellas looks to replace its ageing OAB drug Vesicare

Clinical News

Quintiles inks five-year clinical development partnership with Merck Serono

Fresh from returning to public ownership with a US$947 million offering, Quintiles has made a significant addition to its roster of strategic alliances in the form of a five-year clinical development agreement with Merck Serono.
Health Research Authority sets out stall on trial transparency

Making trial registration a condition of Research Ethics Committee approval and working with research funders and sponsors to set standards for access to data and human tissue are among proposals by the UK’s Health Research Authority (HRA) to ensure the publication of clinical and other health-research findings.
Society for Clinical Research Sites allies with Brazilian Society of Investigators

The Society for Clinical Research Sites has formed a “strategic alliance” with Dr Luis Augusto Russo, president of the Brazilian Society of Investigators.